A review on recent advances in drugs for lung cancer treatment

A review on recent advances in drugs for lung cancer treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Opis bibliograficzny
1. autor:	Noor, Fouzia
Kolejni autorzy:	Akter, Raushanara
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2024
Hasła przedmiotowe:	Lung cancer Recent advances Drugs Resistance Mechanism of action Lung cancer > Treatment
Dostęp online:	http://hdl.handle.net/10361/22049

Podobne zapisy

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Wydane: (2023)

A review on targeted therapies for lung cancer
od: Ashraf, Anushey
Wydane: (2023)

Molecules associated with the development of lung cancer
od: Rahman, Adree, i wsp.
Wydane: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Wydane: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
od: Jeba, Joynob
Wydane: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
od: Razna, Amrin Islam
Wydane: (2019)

Immunotherapy in the Management of Lung Cancer
od: Tasnim, Humayra
Wydane: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Wydane: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
od: Das, Reshita
Wydane: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Wydane: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Wydane: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Wydane: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Wydane: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
od: Shabnam, Musharrat
Wydane: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Wydane: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Wydane: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
od: Khondokar, Faiza
Wydane: (2022)

A comprehensive review on drug repurposing in cancer treatment
od: Sarkar, Onusree
Wydane: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
od: Raihan, Dilraj
Wydane: (2024)

Lung cancer detection and classification using machine learning
od: Arefin, Mahbubul, i wsp.
Wydane: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
od: Nandy, Aditi
Wydane: (2022)

Recent advancement on breast cancer detection and treatment
od: Rahman, Sanjida
Wydane: (2023)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
od: Chakraborty, Anuradha
Wydane: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Wydane: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
od: Nahar, Kamrun
Wydane: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
od: Mukti, Roushney Fatima, i wsp.
Wydane: (2016)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
od: Hasan, Samir, i wsp.
Wydane: (2024)

Natural products and their combinatory effects in breast cancer treatment
od: Siddique, Md. Ayman
Wydane: (2021)

Precision medicine in four deadliest Cancers of the world : present practices & future prospects
od: Islam, Ankita
Wydane: (2022)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
od: Hoque, Syeda Mehren
Wydane: (2024)

Microneedles in pain management of Cancer
od: Islam, Shafiqul
Wydane: (2022)

Breast cancer therapy through Liposomal drug delivery system
od: Ome, Nusrat Jahan
Wydane: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
od: Hossain, Safa Binte
Wydane: (2019)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
od: Muntaha, Habibatul
Wydane: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Wydane: (2024)

Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Wydane: (2021)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
od: Kamal, Tasnova
Wydane: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
od: Parvez, Safi
Wydane: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
od: Nashrah, Zannatul
Wydane: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
od: Rahman, Qazi Ashrafur
Wydane: (2018)